Analysis
Prostate-specific antigen screening can be beneficial to younger and at-risk men
Monique J. Roobol, Chris H. Bangma and Stacy Loeb
CMAJ January 08, 2013 185 (1) 47-51; DOI: https://doi.org/10.1503/cmaj.111962
Monique J. Roobol
From the Department of Urology (Roobol, Bangma), Erasmus University Medical Centre, Rotterdam, the Netherlands; and the Department of Urology (Loeb), New York University, New York, NY
PhD MscChris H. Bangma
From the Department of Urology (Roobol, Bangma), Erasmus University Medical Centre, Rotterdam, the Netherlands; and the Department of Urology (Loeb), New York University, New York, NY
MD PhDStacy Loeb
From the Department of Urology (Roobol, Bangma), Erasmus University Medical Centre, Rotterdam, the Netherlands; and the Department of Urology (Loeb), New York University, New York, NY
MDArticle Figures & Tables
There are no figures or tables available.
In this issue
Article tools
Respond to this article
Prostate-specific antigen screening can be beneficial to younger and at-risk men
Monique J. Roobol, Chris H. Bangma, Stacy Loeb
CMAJ Jan 2013, 185 (1) 47-51; DOI: 10.1503/cmaj.111962